Clinical
January MIMS Update
Some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Faecal microbiota (Biomictra) works via restoration of gut microbial diversity. Biomictra is indicated …
A boost to coverage
Shingrix addition to NIP boosted uptake by 40%, finds leading research centre Shingles vaccination coverage increased by 40% among adults aged ≥65 years in the first 12 months after Shingrix …
Extra time for Telstra Health to meet eNRMC conformance
Concerns over the potential clinical risks around shifting patients from Telstra Health’s MedPoint medication charts to a paper-based system behind extension to conformance deadline Telstra Health has been given until April …
Research Roundup
Debbie Rigby rounds up the latest in research news Efficacy and Safety of Bisphosphonates for Complex Regional Pain Syndrome A systematic review and meta-analysis of 11 RCTs has concluded that …
Scheduling change for adrenaline product
Intranasal adrenaline soon to become Pharmacist Only for treating anaphylaxis The Therapeutic Goods Administration has decided to downschedule intranasal preparations containing 2% or less of adrenaline to Pharmacist Only (Schedule …
December MIMS Update
Some of the recent changes to the medicines landscape, with new indications and contraindications New Indications Durvalumab (Imfinzi) in combination with gemcitabine and cisplatin is now also indicated as neoadjuvant …
‘Your insights have been invaluable’
Assistant minister and pharmacist Emma McBride says the government will reveal its plan to tackle critical workforce shortages, as hospital pharmacy services plummet due to supply gaps The Federal …
‘This work strengthens our national frameworks’
Slade Pharmacy will present eight abstracts at the 2025 Advanced Pharmacy Australia (AdPha) Medicines Management Conference and the COSA–IPOS Annual Scientific Meeting this week The 60-year-old pharmacy group said it’s …
‘Rapid’ uptake of CF triple therapy
PBS listing of the combination medicine has led to improved quality of life for patients with cystic fibrosis (CF), says drug utilisation committee Nearly 90% of Australians prescriptions of cystic …
Fourfold jump in ADHD meds poisonings: study
“Just one double dose of clonidine can put a child in hospital”, research warns, as poisonings linked to ADHD medications surge Data from the NSW Poisons Information Centre (NSW PIC) …
November MIMS update
Some of the recent changes to the medicines landscape, with new products, presentations, indications and contraindications New Products Elafibranor (Iqirvo) and its main active metabolite GFT1007 are peroxisome proliferator-activated receptor …
Prescriber Bag reviewed
Furosemide, Covid-19 antiviral tablets cited in PBAC recommendations on items to be added to or removed from the bag All currently listed Prescriber Bag benefits remain suitable, except Covid-19 antiviral …